<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>medsurfnews.com</title><link>http://mn.medsurfnews.com</link><description>Le ultime risorse da Medsurfnews.com</description><language>it</language><pubDate></pubDate><copyright>Healthwaregroup.com</copyright><webmaster>francesco.raimondo@healthware.it</webmaster><image><title>Medsurfnews Rss</title><url>http://mn.medsurfnews.com/images/logo.jpg</url><link>http://mn.medsurfnews.com</link></image>

	
	
<item>

<title>Hemochromatosis: new guidelines</title>
<link>http://mn.medsurfnews.com/contents/it/7200/display/hemochromatosis-new-guidelines.aspx</link>
<pubDate>Mon, 2 Apr 2012 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[The consequences of hemochromatosis can be severe, ranging from cirrhosis to liver cancer, diabetes and heart failure, hence early diagnosis is particularly important for what is considered the most common genetic disorder among Caucasians. Unfortunately, it has been shown recently that many [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7200_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7200_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Statins in Patients with Fatty Liver Disease</title>
<link>http://mn.medsurfnews.com/contents/it/6638/display/statins-in-patients-with-fatty-liver-disease.aspx</link>
<pubDate>Mon, 25 Jul 2011 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[When a hyperlipemia is present, we can often find high levels of transaminases as an effect of  non-alcoholic fatty liver disease (NAFLD), and previous trials have suggested that statins can decrease the levels of transaminases, improving liver histology. In these patients, however, there is an [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/6638_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/6638_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Prevention of Esophageal Varices Rupture</title>
<link>http://mn.medsurfnews.com/contents/it/6271/display/prevention-of-esophageal-varices-rupture.aspx</link>
<pubDate>Mon, 14 Mar 2011 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[Guidelines recommend the use of a beta-blocker or an endoscopic ligation in order to prevent the risk of the first bleeding due to the rupture of esophageal varices in liver cirrhosis, while, for the prevention of relapses, the association of ligation with beta-blocker has been more effective than [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/6271_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/6271_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Pioglitazone and Vitamin E in NASH</title>
<link>http://mn.medsurfnews.com/contents/it/6019/display/pioglitazone-and-vitamin-e-in-nash.aspx</link>
<pubDate>Mon, 15 Nov 2010 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[We have not got a specific therapy for non-alcoholic steatohepatitis (NASH), since there are many trials on various substances, but most of them are not randomized or they have been too short or with endpoints of unclear efficacy. Now, a phase-III, multicentric, double-blinded trial has been [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/6019_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/6019_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Overweight and Liver Risks</title>
<link>http://mn.medsurfnews.com/contents/it/5852/display/overweight-and-liver-risks.aspx</link>
<pubDate>Mon, 4 Oct 2010 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[From previous trials, we know that the presence of overweight can imply even severe risks for the liver, but the interaction between overweight and alcohol intake is not completely cleared up yet, so some answers to this situation are searched. In a retrospective trial performed in Scotland, 9600 [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/5852_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/5852_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Alcohol and Non-Alcoholic Steatohepatitis</title>
<link>http://mn.medsurfnews.com/contents/it/5890/display/alcohol-and-non-alcoholic-steatohepatitis.aspx</link>
<pubDate>Mon, 4 Oct 2010 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[Some patients affected by non-alcoholic steatohepatitis (NASH) present other clinical conditions (hyperlipidemia, diabetes) for which a moderate alcohol intake implies some benefits, but we know which are the effects of a moderate intake of small amounts of alcohol on NASH, a clinical entity with [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/5890_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/5890_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Normal Values of ALT</title>
<link>http://mn.medsurfnews.com/contents/it/5412/display/normal-values-of-alt.aspx</link>
<pubDate>Mon, 21 Jun 2010 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[It is normal to see very variable limits in the normality range as to the values of transaminases, according to the laboratory performing the exam, and this variability often creates some problems to the patient and to the general practitioner, since an increase in this parameter could mean a liver [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/5412_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/5412_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Statins and Gallstones</title>
<link>http://mn.medsurfnews.com/contents/it/5272/display/statins-and-gallstones.aspx</link>
<pubDate>Mon, 24 May 2010 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[Since the use of statins is associated with a reduction in cholesterol production, these drugs should theoretically have a role in cholesterinic biliary lithiasis, but the trials performed up to now have only given inconclusive results. Now, some researchers in England have used a registry of [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/5272_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/5272_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Analgesic Safety in Cirrhosis</title>
<link>http://mn.medsurfnews.com/contents/it/4958/display/analgesic-safety-in-cirrhosis.aspx</link>
<pubDate>Mon, 22 Mar 2010 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[Paracetamol-induced liver toxicity (both following an ingestion of high doses and for very-long-term therapies) is the commonest cause of acute liver failure in the USA, so researchers have wondered on the problem of the safety of analgesics and OTC NSAIDs. In order to better evaluate their [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/4958_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/4958_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Pioglitazone in Fatty Liver </title>
<link>http://mn.medsurfnews.com/contents/it/3241/display/pioglitazone-in-fatty-liver-.aspx</link>
<pubDate>Mon, 16 Feb 2009 12:00:00 +0200</pubDate>
<category>Epatologia</category>
<description><![CDATA[Non-alcoholic fatty liver is more and more increasing and not only as a histological curiosity, but also as a clinical condition implying even serious consequences. Thiazolidinediones, approved by FDA for diabetes treatment, improve liver histology in diabetic patients, so researchers have thought [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/3241_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/3241_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	</channel></rss>
	



